St. Jude/Hancock Jaffe Laboratories
This article was originally published in The Gray Sheet
Executive Summary
Firms' joint venture, The Heart Valve Company, commences international clinical trials with the first implantation of its SJM X-Cell heart valve bioprothesis March 17 at Glenfield Hospital in Leicester, England. The valve incorporates "an antimineralization process which removes potential calcification sites from the valve tissue," and "a special sterilization process that significantly simplifies the rinse procedure for the valve before implantation, thereby saving valuable operating room time," St. Jude claims. Clinicals will expand to other European centers "shortly," leading to a possible IDE application in 1994, according to the firm ("The Gray Sheet" March 7, I&W-3)
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.